Voyageur Pharmaceuticals Company Description

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah.

It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products.

Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019.

The company is headquartered in Calgary, Canada.

Voyageur Pharmaceuticals Ltd.

Country	Canada
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
CEO	Brent Willis

Contact Details

Address: 4103B Centre Street NW Calgary, Alberta T2E 2Y6 Canada
Website	voyageurpharmaceuticals.ca

Stock Details

Ticker Symbol	VM
Exchange	TSX Venture Exchange
Fiscal Year	December - November
Reporting Currency	CAD
ISIN Number	CA92918C1014
SIC Code	2834

Key Executives

Name	Position
Brent Willis Bsc.Eng	President, Chief Executive Officer and Director
Bradley Craig Willis P.Eng.	Founder, Chief Operating Officer and Director
Albert Deslauriers	Chief Financial Officer
Dr. Iryna Saranchova M.D., Ph.D.	Chief Scientific Officer
Dr. Ibrahim Hashmi	Vice President of Business Development
Ethan Mohan	Executive Vice President